Pfizer and manufacturer Tris Pharma have agreed to hand over $41.5 million to lay to rest a 2023 lawsuit accusing the ...
GlobalData on MSN
Pfizer and Tris agree with Texas over ADHD drug allegations
Pfizer and Tris Pharma have agreed to pay $41.5m to settle allegations by the Texas Attorney General Ken Paxton ...
Texas Attorney General Paxton secures a $41.5 million settlement with Pfizer and Tris Pharma over allegations of providing ...
Free Malaysia Today on MSN
Pfizer, Tris Pharma settle for US$41.5mil in Texas ADHD drug case
The settlement ends a 2023 lawsuit alleging pharmaceutical companies manipulated ADHD medication quality tests.
The settlement resolves a 2023 lawsuit that accused the pharmaceutical companies of manipulating quality control tests of a medication used to treat ADHD.
Pfizer Inc. and Tris Pharma Inc. will pay the state of Texas $41.5 million to settle claims that it allegedly provided ...
Benzinga on MSN
Pfizer Settles Suit Tied To Children's ADHD Medication
Pfizer and Tris Pharma agreed to a $41.5 million settlement with Texas over claims they manipulated quality-control testing ...
Texas Attorney General Ken Paxton has secured a $41.5M settlement with Pfizer (PFE) and Tris Pharma for allegedly providing adulterated ...
Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded ...
Pfizer (PFE) stock is in focus as the firm joins Tris Pharma to settle a lawsuit over supplying an adulterated ADHD drug to ...
Pfizer and Tris Pharma agreed to pay $41.5 million to settle allegations they altered testing methods to ensure their ADHD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results